Amanda S. Marshall
Former U.S. Attorney
(Local Counsel)
Lynette Byrd
Former Assistant
U.S. Attorney
Roger Bach
Former Special
Agent
(OIG & DEA)
Joe Brown
Former U.S. Attorney
Dr. Nick Oberheiden
Attorney & Founder
What is “Risk Management” in the Healthcare Setting?
Working in healthcare inherently presents several types of risk. Risks such as those associated with treating patients, storing confidential patient records, maintaining a safe work environment, and maintaining emergency response capabilities are front-and-center for many providers and facility administrators, but the reality is that these only represent one subset of...
Read more
Coronavirus Healthcare Fraud
Healthcare providers, medical technology companies, and other entities in the healthcare sector are facing heavy scrutiny during the coronavirus pandemic. Providers and companies accused of fraud can face steep penalties, and they must engage experienced federal defense counsel at the first sign of an audit or investigation. Healthcare providers are...
Read more
IRS Fraud Related to COVID-19
Like other federal agencies, the Internal Revenue Service (IRS) is continuing to enforce individuals' and companies' obligations during the novel coronavirus (COVID-19) pandemic. While some tax relief is being offered, the IRS is also pursuing audits and investigations to uncover fraud during the crisis. The economic impacts of the COVID-19...
Read more
Healthcare Fraud Cases Targeting Vascular Surgeons and Vein Procedures
The Centers for Medicare and Medicaid Services (CMS) and U.S. Department of Justice (DOJ) have recently been targeting vascular surgeons in Medicare fraud cases. Allegations from patients, personnel, and other sources are leading to invasive investigations and charges under the False Claims Act. Like all healthcare providers, vascular surgeons are...
Read more
President Trump’s Coronavirus National Emergencies Act Declaration: The Ultimate Guide on Economic and Legal Impacts for Businesses
Dr. Nick OberheidenAttorney-at-LawDirect: 888-680-1745 The National Emergencies Act endows the President with broad authority to direct (and shut down) domestic and international commerce during the novel coronavirus (COVID-19) outbreak. Here is what companies in the United States need to know. On March 13, 2020, President Trump declared a national emergency...
Read more
Coronavirus in the Workplace: What Do Employers Need to Know?
Companies of all sizes have obligations during the coronavirus pandemic. Here is what employers need to know in order to protect their employees and themselves. Individuals and businesses in the United States have suddenly and unexpectedly been thrust into a new normal. While the novel coronavirus (COVID-19) will eventually be...
Read more
What Can (and Should) Companies Do to Prepare for the Novel Coronavirus (COVID-19)?
As the Impact of the Novel Coronavirus Pandemic Continue to Broaden, Companies Must Ensure that They are Adequately Prepared The novel coronavirus (COVID-19) is continuing proliferate across the United States and around the world; and, while local, state, and federal authorities are undertaking significant efforts to stop the spread of...
Read more
The Families First Coronavirus Response Act: What Does it Mean for Employers?
The Families First Coronavirus Response Act has passed the House and is now making its way through the Senate. Here is what employers need to know. On March 14, 2020, the U.S. House of Representatives passed the Families First Coronavirus Response Act (the "FFCRA") by a vote of 363-40. The...
Read more
Coronavirus & SEC Disclosure
Do Publicly-Traded Companies Have a Duty to Disclose Coronavirus Cases Under SEC Rules? The coronavirus pandemic has sent shockwaves through the U.S. and global securities markets. The Dow Jones industrial average has plunged into its first bear market since the financial crisis of the late 2000s, and the federal government...
Read moreFDA Acknowledgement Form Concerning Violations of 21 U.S.C. Section 331
Recently, the U.S. Food and Drug Administration (FDA) has been having doctors sign forms acknowledging that their prescription drug practices could violate 21 U.S.C. Section 331 and other federal laws. As a physician, you do your best to comply with the law, and the last thing you want to do...
Read more